ROME (Reuters) - Administering the AstraZeneca vaccine to those aged up to 65 would not be wrong, given the delays in supplies to Italy, the head of national medicines agency AIFA said on Monday.
When the European Medicines Agency (EMA) approved the vaccine in January, it said there were not enough results to show how well it worked for those older than 55, though it could still be given to older people.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!